See All Slides - tctmd.com

Slides

Presentation

PARTNER: Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Presenter: T.M. Nazif

January 19, 2015

Presentation

Effect of a Shortened Duration Eptifibatide Infusion (75 mg) as Adjunctive Therapy for PCI

Presenter: Scott D. Nei

January 15, 2015

Presentation

TE-PROVE: 1-year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium PES

Presenter: C. Tamburino

January 14, 2015

Presentation

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

Presenter: Ram?n L?pez M?nguez

January 14, 2015

Presentation

The Effect of AKI After Revascularization on the Development of CKD and Mortality in Patients with Chronic Limb Ischemia

Presenter: P. Arora

January 13, 2015

Presentation

Anticoagulant Therapy and Outcomes in Patients With Prior or Acute HF and ACS

Presenter: Jan H. Cornel

January 13, 2015

Presentation

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

Presenter: Bernard Chevalier

January 12, 2015

Presentation

Outcomes After CAS in Medicare Beneficiaries,  2005-2009

Presenter: J.J. Jalbert

January 11, 2015

Presentation

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

Presenter: Gennaro Galasso

January 11, 2015

Presentation

Trends in the Occurrence of New Conduction Abnormalities After TAVR

Presenter: R.M.A. van der Boon

January 08, 2015

Advertisement

Slides

PARTNER: Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Effect of a Shortened Duration Eptifibatide Infusion (75 mg) as Adjunctive Therapy for PCI

TE-PROVE: 1-year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium PES

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

The Effect of AKI After Revascularization on the Development of CKD and Mortality in Patients with Chronic Limb Ischemia

Anticoagulant Therapy and Outcomes in Patients With Prior or Acute HF and ACS

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

Outcomes After CAS in Medicare Beneficiaries,  2005-2009

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

Trends in the Occurrence of New Conduction Abnormalities After TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content